STERILE PROVOCHOLINE SOLUTION PLUS

Land: Kanada

Sprache: Englisch

Quelle: Health Canada

Wirkstoff:

METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE; METHACHOLINE CHLORIDE

Verfügbar ab:

METHAPHARM INC

ATC-Code:

V04CX

INN (Internationale Bezeichnung):

OTHER DIAGNOSTIC AGENTS

Dosierung:

0.25MG; 0.0625MG; 1MG; 4MG; 16MG; 0.125MG; 0.50MG; 2MG; 8MG

Darreichungsform:

SOLUTION

Zusammensetzung:

METHACHOLINE CHLORIDE 0.25MG; METHACHOLINE CHLORIDE 0.0625MG; METHACHOLINE CHLORIDE 1MG; METHACHOLINE CHLORIDE 4MG; METHACHOLINE CHLORIDE 16MG; METHACHOLINE CHLORIDE 0.125MG; METHACHOLINE CHLORIDE 0.50MG; METHACHOLINE CHLORIDE 2MG; METHACHOLINE CHLORIDE 8MG

Verabreichungsweg:

INHALATION

Einheiten im Paket:

100

Verschreibungstyp:

Prescription

Therapiebereich:

OTHER DIAGNOSTIC AGENTS

Produktbesonderheiten:

Active ingredient group (AIG) number: 0951577001; AHFS:

Berechtigungsstatus:

CANCELLED PRE MARKET

Berechtigungsdatum:

2021-04-19

Fachinformation

_Page 1 of 34 _
PRESCRIBING INFORMATION
PR
STERILE PROVOCHOLINE
®
SOLUTION,
PR STERILE PROVOCHOLINE
®
SOLUTION PLUS AND
PR
STERILE PROVOCHOLINE
®
SOLUTION 16
methacholine chloride solution for inhalation
0.0625, 0.125, 0.25, 0.5, 1, 2, 4, 8, and 16 mg/mL
PR
PROVOCHOLINE
®
methacholine chloride powder USP
100 mg, 160 mg, 320 mg, 1280 mg and 1600 mg
Cholinergic / Diagnostic Aid (Bronchial Asthma)
Methapharm Inc.
Date of Preparation: 31 May 2001
81 Sinclair Blvd.
Brantford, Ontario
Date of Revision: 29 January 2008
N3S 7X6
Control #119812
_Page 2 of 34 _
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
..........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
..............................................................................3
CONTRAINDICATIONS
...................................................................................................4
WARNINGS AND PRECAUTIONS
..................................................................................4
ADVERSE REACTIONS
....................................................................................................7
DRUG INTERACTIONS
....................................................................................................7
DOSAGE AND ADMINISTRATION
................................................................................8
OVERDOSAGE
................................................................................................................23
ACTION AND CLINICAL PHARMACOLOGY
............................................................23
STORAGE AND STABILITY
..........................................................................................24
SPECIAL HANDLING INSTRUCTIONS
.......................................................................24
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................25
PART II: SCIENTIFIC INFORMATION
....................